Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)

Hepatitis B Virus Infection Clinical Trial

Official title:
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process

Status Completed

Clinical Trial Summary

To describe the immunogenicity and safety of modified process hepatitis B vaccine administered to renal predialysis and dialysis patients

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00440297
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 3
Start date	December 2006
Completion date	May 2008

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05392387` - Treatment and Prognosis of Patients With Chronic HBV Infection
Recruiting	`NCT06023056` - Hepatitis B Vaccination After Neonatal Surgery
Recruiting	`NCT05051098` - A Non-interventional Registry for Patients With Hepatitis B Virus Infection
Recruiting	`NCT03864263` - Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents
Completed	`NCT02798549` - HBV Virions Bound Proteins	N/A
Recruiting	`NCT03695029` - Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus	Phase 4
Terminated	`NCT03762681` - A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection	Phase 1